Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo vs Retin-A Micro Tolerability in Acne
NCT01522456Phase 4Completed
- Sponsor
- Galderma
- Start
- Apr 2012
- Primary completion
- May 2012
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of adapalene + benzoyl peroxide in acne vulgaris (2 arms), sponsored by Galderma. Primary endpoints: Worst Postbaseline Tolerability (Erythema), Worst Postbaseline Tolerability (Scaling) and 2 more. Started Apr 2012; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01522456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522456.